The Role of PET Scanning in the Evaluation of Patients With Kidney Disease

Advances in Chronic Kidney Disease
Namrata Krishnan, Mark A Perazella

Abstract

Patients with underlying kidney disease are often required to undergo imaging for a variety of purposes including diagnosis and prognosis. A test that is being increasingly used with for this group of patients is the positron emission test (PET) scan. In addition, combining the nuclear medicine technique (PET) with computed tomography scan allows additional imaging advantages over either alone. These imaging modalities are commonly used for a number of extrarenal indications (ie, cancer, coronary artery disease, central nervous system disease, infectious diseases, and others). They have also been used for diagnosis of acute tubulointerstitial nephritis, evaluation and management of retroperitoneal fibrosis, identifying infection within kidney and liver cysts, and distinguishing complex kidney cysts from kidney cancer in patients with underlying CKD. We will review PET scan utility in patients with kidney disease.

Citations

Aug 14, 2018·Journal of Magnetic Resonance Imaging : JMRI·Jia-Ying ZhouSheng-Hong Ju
Sep 11, 2019·Current Opinion in Critical Care·Fernando Caravaca-FontánManuel Praga
Feb 8, 2020·Stroke and Vascular Neurology·John M Chapel, Guijing Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Related Papers

Ryōikibetsu shōkōgun shirīzu
Y Kobayashi, S Tateno
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
H Yamabe
Clinical Journal of the American Society of Nephrology : CJASN
Frederic Rahbari-OskouiArlene Chapman
Nihon rinsho. Japanese journal of clinical medicine
Seiichi Matsuo
© 2022 Meta ULC. All rights reserved